Challenges for the implementation of an outpatient parenteral antimicrobial therapy clinic system in Mexico

Laura Nuzzolo-Shihadeh1, Adrián Camacho-Ortiz1

  • 1Centro de Infusión de Antimicrobianos y Tratamiento de Enfermedades infecciosas (CIATI), Department of Infectious Diseases, University Hospital Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, México.

IJID Regions
|March 18, 2026
PubMed

Insights

Outpatient parenteral antimicrobial therapy (OPAT) is feasible and accepted in Mexico, despite limited resources. Challenges in Latin America include infrastructure and funding, requiring policy advocacy for sustainable OPAT programs.

Area of Science:

  • Infectious Diseases
  • Health Services Research
  • Global Health

Background:

  • Outpatient parenteral antimicrobial therapy (OPAT) offers benefits like reduced hospital stays and costs.
  • OPAT services are globally established but scarce in Mexico, with most treatments occurring informally.
  • Existing informal treatments lack standardized protocols and trained staff.

Purpose of the Study:

  • To discuss the challenges and potential solutions for establishing OPAT services in Mexico and similar healthcare settings.
  • To highlight the feasibility and acceptance of OPAT in resource-limited environments.
  • To advocate for policies and evidence supporting OPAT program sustainability.

Main Methods:

  • Review of institutional experience with OPAT in Mexico.
  • Analysis of barriers to OPAT implementation in Latin America.
  • Discussion of strategies for enhancing OPAT sustainability and access.

Main Results:

  • OPAT is demonstrated to be feasible and well-accepted, even among patients with limited financial and social resources.
  • Significant barriers to OPAT implementation in Latin America include infrastructure, funding, and workforce limitations.
  • Caregiver education and access to clinical services, laboratory monitoring, and physician follow-up are crucial for successful OPAT.

Conclusions:

  • Establishing sustainable OPAT programs in Mexico and Latin America requires addressing infrastructure, funding, and workforce challenges.
  • Advocacy for supportive policies and demonstrating cost-effectiveness are critical for long-term OPAT program viability.
  • Integrated strategies involving caregiver education and comprehensive clinical support are essential for enhancing OPAT access and sustainability.

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
3
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
88
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
3.6K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
604
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
308